A Phase-II Study Of TOMUDEX Plus Radiotherapy In Subject With Inoperable or Recurrent Rectal Cancer

NCT00590278 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Inoperable or Recurrent Rectal Cancer

Interventions

DRUG: Tomudex
PROCEDURE: Radiotherapy
PROCEDURE: Haematology
PROCEDURE: Biochemistry

Sponsor

AstraZeneca